テストステロンによる心循環再極化電流の非転写的調節
Chang-Xi Bai1, Junko Kurokawa, Masaji Tamagawa
1Department of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Tokyo 101-0062, Japan.
Circulation
|September 15, 2005
まとめ
テストステロンは,カリウム電流を強化し,カルシウム電流を抑制することにより,心臓のアクションポテンシャル期間を短縮し,男性におけるQTc間隔に影響を与える可能性があります. この効果には,酸化窒素のシグナル伝達と非転写的調節が含まれています.
科学分野:
- 心血管生理学 心血管の生理学
- 分子心臓病学 分子心臓病学
- エンドクリノロジー エンドクリノロジー
背景:
- 女性は男性よりもQTc間隔が長く,心拍不良のリスクが高くなります.
- テストステロンは,心室再極化における性別の違いに関与しています.
- テストステロンの心臓のイオン電流への影響に関するデータは限られている.
研究 の 目的:
- テストステロンの心筋細胞に対する電気生理学的効果を調査する.
- テストステロンの作用の根底にあるイオンメカニズムを解明する.
- テストステロンの効果に関与するシグナル伝達経路を探求するために.
主な方法:
- 孤立したギニア豚の心室筋細胞におけるパッチクランプ電気生理学.
- アクションポテンシャル持続時間 (APD) と膜電流の評価.
- 特定のイオンチャンネルとシグナル伝達経路の薬理学的阻害.
- タンパク質のリン酸化のための免疫ブロット分析.
主要な成果:
- テストステロンは生理学的濃度でAPDを急速に短縮しました.
- APDの縮小は,IKの強化とI (Ca,L) 抑制によるものです.
- 酸化窒素 (NO) は,NOS3.3経由でテストステロンの効果を媒介した.
- テストステロンは,受容体,c-Src,PI3K,およびAkt経路を通じたAktとNOS3のリン酸化を誘導した.
結論:
- テストステロンは,トランスクリプション外でIKsとI(Ca,L) を調節する.
- これは,心臓の再偏極化を制御するための新しいメカニズムを表しています.
- テストステロンの作用は,QTc間隔調節におけるアンドロゲンの役割に寄与する可能性があります.
関連する概念動画
G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Regulation of Heart Rates
6.0K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.0K
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597


